Physician profile
Theodore T Tsaltas
NPI 1679594881
$853,328.61
in general payments reported to CMS, 2019-2025
3 companies · $190K in 2025
The $190K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $43K · 2021: $92K · 2022: $119K · 2023: $209K · 2024: $201K · 2025: $190K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $598K · Travel and Lodging: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $598,198.67 |
| Travel and Lodging | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Plasma INC. | $486,818.67 | 2023-2025 | |
| Csl Behring | $254,629.94 | 2020-2022 | |
| Kedplasma LLC | $111,880.00 | 2023-2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Tsaltas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.